A SYSTEMATIC LITERATURE REVIEW (SLR) TO SUPPORT NETWORK META-ANALYSES (NMA) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) FOLLOWING PD-1/L1 INHIBITORS

被引：0
|
作者：
Shah, S. N. [1 ]
Wissinger, E. [2 ]
Ballew, N. [2 ]
Hepp, Z. [3 ]
机构：
[1] Astellas Pharma Inc, Northbrook, IL USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Seattle Genet, Bothell, WA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN40
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [1] Systematic literature review (SLR) and network meta-analysis (NMA) of first-line therapies (1L) for locally advanced/metastatic urothelial carcinoma (la/mUC).
    Bloudek, Lisa
    Hepp, Zsolt
    Mckay, Caroline
    Derleth, Christina Louise
    Lill, Jennifer Susan
    Lenero, Enrique
    Wright, Phoebe
    Ramsey, Scott David
    Sullivan, Sean D.
    Devine, Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)
    Bloudek, Lisa
    Wright, Phoebe
    McKay, Caroline
    Derleth, Christina Louise
    Lill, Jennifer Susan
    Lenero, Enrique
    Hepp, Zsolt
    Ramsey, Scott David
    Sullivan, Sean D.
    Devine, Beth
    CURRENT ONCOLOGY, 2023, 30 (04) : 3637 - 3647
  • [3] Systematic literature review (SLR) and network meta-analysis (NMA) of first-line (1L) therapies for locally advanced/metastatic urothelial carcinoma (la/mUC)
    Bloudek, L.
    Hepp, Z.
    Mckay, C.
    Devine, B.
    Derleth, C.
    Lill, J.
    Lenero, E.
    Wright, P.
    Ramsey, S. D.
    Sullivan, S. D.
    ANNALS OF ONCOLOGY, 2021, 32 : S715 - S715
  • [4] PD-1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta-analysis
    Mao, Longkun
    Yang, Meihua
    Fan, Xinxiang
    Li, Wenjie
    Huang, Xiaodong
    He, Wang
    Lin, Tianxin
    Huang, Jian
    CANCER INNOVATION, 2023, 2 (03): : 191 - 202
  • [5] COST-EFFECTIVENESS (CE) ANALYSES FOR FIRST-LINE (1L) TREATMENT OF ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Braun, N.
    Auti, P.
    Arca, E.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S44 - S44
  • [6] Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy
    Hepp, Zsolt
    Shah, Sonali N.
    Liang, Shang-Ying
    Tan, Katherine
    Balakrishna, Shreya
    FUTURE ONCOLOGY, 2021, 17 (32) : 4343 - 4353
  • [7] Clinical outcomes with split-dose cisplatin-based regimens in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a systematic literature review (SLR) and network meta-analysis (NMA).
    O'Dwyer, Richard Thomas
    Kearney, Mairead
    Musat, Mihaela
    Gulas, Ioana
    Guenther, Silke
    Hubscher, Elizabeth
    Moradian, Hoora
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 589 - 589
  • [8] Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma
    Tang, Quanqing
    Li, Shihao
    Huang, Gaozhen
    Liu, Hongwei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [9] Impact of angiotensin blockade on response to PD1/L1 inhibitors for patients with metastatic urothelial carcinoma (mUC).
    Skelton, William Paul
    Jain, Rohit K.
    Curran, Catherine
    Pond, Gregory Russell
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Youngchul
    Nuzzo, Pier Vitale
    Abou Alaiwi, Sarah
    Nassar, Amin
    Jain, Rakesh K.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [10] Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma
    Wei, Xiao X.
    Werner, Lillian
    Teo, Min Y.
    Rosenberg, Jonathan E.
    Koshkin, Vadim S.
    Grivas, Petros
    Szabados, Bernadett
    Morrison, Laura
    Powles, Thomas
    Carril-Ajuria, Lucia
    Castellano, Daniel
    Velho, Pedro Isaacsson
    Hahn, Noah M.
    McKay, Rana R.
    Raggi, Daniele
    Necchi, Andrea
    Kanesvaran, Ravindran
    Alerasool, Parissa
    Gaines, Jacob
    Galsky, Matthew
    Bellmunt, Joaquim
    Sonpavde, Guru
    JOURNAL OF UROLOGY, 2021, 205 (02): : 414 - 419
12345